FDA Issues New Guidance on Assessing REMS By Sam | February 5, 2019 The FDA released two draft guidances outlining the agency’s latest thinking on assessments of risk evaluation and mitigation strategy (REMS) programs. Source: Drug GMP Report Posted in Drug GMP Report